caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1528350253

Elizabeth BolenM.D.

PRACTICESEATTLE EXTRACORPOREAL LLCSee all providers at this practice →
Internal MedicineSeattle, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
4,020
Beneficiaries
—
Total drug cost
$632K
Distinct drugs
93
Brand share
23.4%
Top prescribed drugs
Atorvastatin Calcium404 claims
Amlodipine Besylate298 claims
Levothyroxine Sodium211 claims
Losartan Potassium172 claims
Lisinopril158 claims
REFERRAL NETWORK

Where Elizabeth Bolen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Palmi Shah
Diagnostic Radiology · Chicago, IL
1889
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
687
Unique beneficiaries
—
Total services
900
Distinct HCPCS
7
Medicare payment
$64K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,650 Internal Medicine providers in WA — above median (cohort median 497).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.